EPO must discourage speculative filings, say pharma counsel

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EPO must discourage speculative filings, say pharma counsel

epo-600-comp.jpg

The G2/21 referral on plausibility risks turning the clock back to a wave of ‘prophetic’ patent filings seen in the 1990s, say in-house sources

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login
more from across site and SHARED ros bottom lb

More from across our site

Andrea Stone explains how her in-house experience gives her a unique perspective, and why Ballard Spahr’s combination with Lane Powell made it an ideal time to join
Gift this article